Forced Degradation and Stress Testing of Therapeutic Peptide APIs: ICH Q1A-Aligned Strategy
ICH Q1A-Aligned Strategy for Forced Degradation and Stress Testing An ICH Q1A-aligned strategy for forced degradation and stress testing of […]
Peptide Aggregation Analysis: SEC-MALS, DLS, and AUC for Detecting Aggregated Species
Introduction: The Critical Role of Peptide Aggregation Analysis in Biopharmaceutical Quality Peptide Aggregation Analysis is a critical regulatory and biophysical
Peptide Aggregation Analysis: SEC-MALS, DLS, and AUC for Detecting Aggregated Species Read More »
Best Practices for Toxicological Qualification of Leachables
Introduction to the Advanced Landscape of Toxicological Qualification of Leachables The toxicological qualification of leachables is a critical process that
Best Practices for Toxicological Qualification of Leachables Read More »
Naltrexone PLGA Microsphere Case Study: Controlling Burst Release Through Polymer Design
Introduction: Naltrexone PLGA microsphere burst release is one of the most technically demanding problems in long-acting injectable (LAI) formulation science.
Naltrexone PLGA Microsphere Case Study: Controlling Burst Release Through Polymer Design Read More »
Nitrosamine Analytical Method Development and Validation Services: From LOQ to Full GMP Validation
Introduction: Why Conventional Analytical Methods Are Insufficient for Nitrosamines For pharmaceutical manufacturers facing increasing regulatory scrutiny regarding genotoxic impurities, conventional
Extractables and Leachables (E&L) Testing for Ophthalmic Drug Products: Unique Analytical Challenges
Introduction: Extractables and Leachables Testing for Ophthalmic Drug Products is not simply a regulatory checkbox — it is a critical
Nitrosamine Risk Assessment and Testing Services for NDA and BLA Submissions
Introduction: Nitrosamine impurities are among the most scrutinized safety concerns in modern pharmaceutical development, and no NDA or BLA submission
Nitrosamine Risk Assessment and Testing Services for NDA and BLA Submissions Read More »
Nitrosamine Testing for Beta-Blockers, ACE Inhibitors and Sartans: Drug-Class-Specific CRO Services
Introduction: Why a Single Nitrosamine Testing Panel Is Insufficient for Cardiac Drug Classes Understanding drug-class-specific nitrosamine chemistry is one of
PLGA-Based Ocular Drug Delivery: Implants, Microspheres, and Injectable Systems
Introduction Sustained-release ocular drug delivery continues to represent a major bioengineering challenge because the eye possesses multiple anatomical and physiological
PLGA-Based Ocular Drug Delivery: Implants, Microspheres, and Injectable Systems Read More »
Cyclic Peptide Characterization: LC-MS, NMR, and Structural Confirmation Strategies
Introduction: Why Cyclic Peptide Characterization Requires a Distinct Analytical Framework Characterizing cyclic peptides is far more than a straightforward extension
Cyclic Peptide Characterization: LC-MS, NMR, and Structural Confirmation Strategies Read More »